vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and SouthState Bank Corp (SSB). Click either name above to swap in a different company.
SouthState Bank Corp is the larger business by last-quarter revenue ($661.7M vs $493.8M, roughly 1.3× Pediatrix Medical Group, Inc.). SouthState Bank Corp runs the higher net margin — 34.1% vs 6.8%, a 27.3% gap on every dollar of revenue. Over the past eight quarters, SouthState Bank Corp's revenue compounded faster (37.4% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
SouthState Bank, based in Winter Haven, Florida, is an American bank and a subsidiary of SouthState Corporation, a bank holding company. As of May 26, 2025, the company had 371 branches in South Carolina, North Carolina, Georgia, Florida, Alabama, Virginia, Colorado and Texas.
MD vs SSB — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $661.7M |
| Net Profit | $33.7M | $225.8M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | 15.1% |
| Net Margin | 6.8% | 34.1% |
| Revenue YoY | -1.7% | — |
| Net Profit YoY | 10.5% | 153.5% |
| EPS (diluted) | $0.40 | $2.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $661.7M | ||
| Q4 25 | $493.8M | $581.1M | ||
| Q3 25 | $492.9M | $599.7M | ||
| Q2 25 | $468.8M | $577.9M | ||
| Q1 25 | $458.4M | $544.5M | ||
| Q4 24 | $502.4M | $369.8M | ||
| Q3 24 | $511.2M | $351.5M | ||
| Q2 24 | $504.3M | $350.3M |
| Q1 26 | — | $225.8M | ||
| Q4 25 | $33.7M | $247.7M | ||
| Q3 25 | $71.7M | $246.6M | ||
| Q2 25 | $39.3M | $215.2M | ||
| Q1 25 | $20.7M | $89.1M | ||
| Q4 24 | $30.5M | $144.2M | ||
| Q3 24 | $19.4M | $143.2M | ||
| Q2 24 | $-153.0M | $132.4M |
| Q1 26 | — | 15.1% | ||
| Q4 25 | 9.9% | 54.3% | ||
| Q3 25 | 13.8% | 53.6% | ||
| Q2 25 | 12.8% | 48.8% | ||
| Q1 25 | 7.0% | 22.3% | ||
| Q4 24 | 7.8% | 50.7% | ||
| Q3 24 | 6.6% | 53.1% | ||
| Q2 24 | -31.3% | 49.3% |
| Q1 26 | — | 34.1% | ||
| Q4 25 | 6.8% | 42.6% | ||
| Q3 25 | 14.5% | 41.1% | ||
| Q2 25 | 8.4% | 37.2% | ||
| Q1 25 | 4.5% | 16.4% | ||
| Q4 24 | 6.1% | 39.0% | ||
| Q3 24 | 3.8% | 40.7% | ||
| Q2 24 | -30.3% | 37.8% |
| Q1 26 | — | $2.28 | ||
| Q4 25 | $0.40 | $2.47 | ||
| Q3 25 | $0.84 | $2.42 | ||
| Q2 25 | $0.46 | $2.11 | ||
| Q1 25 | $0.24 | $0.87 | ||
| Q4 24 | $0.37 | $1.88 | ||
| Q3 24 | $0.23 | $1.86 | ||
| Q2 24 | $-1.84 | $1.73 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $2.9B |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $9.0B |
| Total Assets | $2.2B | $68.0B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $2.9B | ||
| Q4 25 | $375.2M | — | ||
| Q3 25 | $340.1M | — | ||
| Q2 25 | $224.7M | — | ||
| Q1 25 | $99.0M | — | ||
| Q4 24 | $229.9M | — | ||
| Q3 24 | $103.8M | — | ||
| Q2 24 | $19.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $9.0B | ||
| Q4 25 | $865.9M | $9.1B | ||
| Q3 25 | $890.7M | $9.0B | ||
| Q2 25 | $833.8M | $8.8B | ||
| Q1 25 | $789.2M | $8.6B | ||
| Q4 24 | $764.9M | $5.9B | ||
| Q3 24 | $732.5M | $5.9B | ||
| Q2 24 | $706.5M | $5.7B |
| Q1 26 | — | $68.0B | ||
| Q4 25 | $2.2B | $67.2B | ||
| Q3 25 | $2.2B | $66.0B | ||
| Q2 25 | $2.1B | $65.9B | ||
| Q1 25 | $2.0B | $65.1B | ||
| Q4 24 | $2.2B | $46.4B | ||
| Q3 24 | $2.1B | $46.1B | ||
| Q2 24 | $2.0B | $45.5B |
| Q1 26 | — | — | ||
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $114.1M | $232.1M | ||
| Q3 25 | $137.3M | $122.4M | ||
| Q2 25 | $137.2M | $72.6M | ||
| Q1 25 | $-117.5M | $-126.3M | ||
| Q4 24 | $133.0M | $354.3M | ||
| Q3 24 | $91.8M | $-246.8M | ||
| Q2 24 | $107.0M | $126.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $215.5M | ||
| Q3 25 | — | $101.7M | ||
| Q2 25 | — | $52.5M | ||
| Q1 25 | — | $-139.1M | ||
| Q4 24 | — | $340.9M | ||
| Q3 24 | — | $-254.2M | ||
| Q2 24 | — | $117.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 37.1% | ||
| Q3 25 | — | 17.0% | ||
| Q2 25 | — | 9.1% | ||
| Q1 25 | — | -25.5% | ||
| Q4 24 | — | 92.2% | ||
| Q3 24 | — | -72.3% | ||
| Q2 24 | — | 33.5% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.9% | ||
| Q3 25 | — | 3.5% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.6% | ||
| Q3 24 | — | 2.1% | ||
| Q2 24 | — | 2.7% |
| Q1 26 | — | — | ||
| Q4 25 | 3.39× | 0.94× | ||
| Q3 25 | 1.91× | 0.50× | ||
| Q2 25 | 3.49× | 0.34× | ||
| Q1 25 | -5.66× | -1.42× | ||
| Q4 24 | 4.36× | 2.46× | ||
| Q3 24 | 4.72× | -1.72× | ||
| Q2 24 | — | 0.96× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
SSB
| Net Interest Income | $561.6M | 85% |
| Noninterest Income | $100.1M | 15% |
